We are live on ! Find out more
EEG

E.E. Geduld Portfolio holdings

AUM $178M
1-Year Est. Return 29.34%
This Fund
S&P 500
This Quarter Est. Return
-7.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$54.2M
Cap. Flow
-$24M
Cap. Flow %
-22.49%
Top 10 Hldgs %
54.93%
Holding
347
New
45
Increased
19
Reduced
60
Closed
132

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.59M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.36M
3
SIMO icon
Silicon Motion
SIMO
+$870K
4
AMZN icon
Amazon
AMZN
+$758K
5
LNKD
LinkedIn Corporation
LNKD
+$596K

Top Sells

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$1.75M
2
CSOD
Cornerstone OnDemand, Inc.
CSOD
+$957K
3
CPRI icon
Capri Holdings
CPRI
+$842K
4
SAGE
Sage Therapeutics
SAGE
+$803K
5
CY
Cypress Semiconductor
CY
+$764K

Sector Composition

Rank Sector Weight
1 Financials 45.84%
2 Miscellaneous 25.05%
3 Healthcare 9.93%
4 Consumer Discretionary 6.85%
5 Technology 4.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ON icon
201
ON Semiconductor
ON
$29.1B
– –
-35,000
Closed -$409K
PCH
202
DELISTED
PotlatchDeltic
PCH
– –
-10,000
Closed -$353K
PGEN icon
203
Precigen
PGEN
$2.57B
– –
-15,179
Closed -$734K
PXLW icon
204
Pixelworks
PXLW
$41.8M
– –
-2,500
Closed -$176K
QCOM icon
205
CALL
Qualcomm
QCOM
$176B
– –
-60,000
Closed -$3.76M
QRVO icon
206
CALL
Qorvo
QRVO
$8.49B
– –
-15,000
Closed -$1.2M
QRVO icon
207
Qorvo
QRVO
$8.49B
– –
-4,500
Closed -$361K
RIO icon
208
PUT
Rio Tinto
RIO
$170B
– –
-20,000
Closed -$824K
RITM icon
209
Rithm Capital
RITM
$5.59B
– –
-10,000
Closed -$152K
SAGE
210
DELISTED
Sage Therapeutics
SAGE
– –
-11,000
Closed -$803K
SBIO icon
211
ALPS Medical Breakthroughs ETF
SBIO
$236M
– –
-10,000
Closed -$355K
SWKS icon
212
CALL
Skyworks Solutions
SWKS
$10.1B
– –
-5,000
Closed -$521K
TCRT icon
213
Alaunos Therapeutics
TCRT
$4.22M
– –
-189
Closed -$341K
TEVA icon
214
CALL
Teva Pharmaceuticals
TEVA
$43.8B
– –
-10,000
Closed -$591K
TLYS icon
215
Tilly's
TLYS
$117M
– –
-20,000
Closed -$193K
UFI icon
216
UNIFI
UFI
$140M
– –
-7,500
Closed -$251K
UUP icon
217
CALL
Invesco DB US Dollar Index Bullish Fund
UUP
$322M
– –
-60,000
Closed -$1.5M
VNCE icon
218
Vince Holding Corp
VNCE
$100M
– –
-1,500
Closed -$180K
VTRS icon
219
CALL
Viatris
VTRS
$19.4B
– –
-15,000
Closed -$1.02M
YPF icon
220
YPF Sociedad Anonima ADS
YPF
$19.8B
– –
-10,000
Closed -$274K
AIOT
221
PowerFleet Inc
AIOT
$403M
– –
-10,000
Closed -$61K
NVRO
222
DELISTED
NEVRO CORP.
NVRO
– –
-5,000
Closed -$269K
ITCI
223
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-7,530
Closed -$241K
INFN
224
DELISTED
Infinera Corporation Common Stock
INFN
– –
-27,500
Closed -$577K
TARO
225
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
– –
-2,000
Closed -$287K
7 8
9
10 11

Similar funds

BC
Bocage Capital San Francisco, California $185M AUM 61.49% 1-Year Est. Return
PFM
PacWest Financial Management Phoenix, Arizona $169M AUM 8.84% 1-Year Est. Return
SRP
Saddle Road Partners Omaha, Nebraska $197M AUM 13.19% 1-Year Est. Return
CF
CenterStar Fund Chicago, Illinois $159M AUM 13.43% 1-Year Est. Return
SA
Steadfast Advisors New York $204M AUM 28.42% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
SIG
Stanford Investment Group Mountain View, California $205M AUM 7.44% 1-Year Est. Return
VWM
Vector Wealth Management Minneapolis, Minnesota $142M AUM 10.42% 1-Year Est. Return

E.E. Geduld's Q3 2015 Portfolio in Review

As of Q3 2015, E.E. Geduld held 347 positions worth $107M, down 34% from $161M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

E.E. Geduld withdrew a net $24M in Q3 2015, closing 132 positions and reducing 60 holdings. Its most notable exit was bluebird bio, an estimated $1.75M position sold in full.

By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 33% a quarter earlier, followed by Miscellaneous and Healthcare.

Against the trend, E.E. Geduld opened a new position in Bristol-Myers Squibb worth $1.48M.

  • E.E. Geduld's largest Q3 2015 buy was Bristol-Myers Squibb: 25,000 shares worth $1.48M.
  • E.E. Geduld added most to Amazon in Q3 2015, an estimated $758K increase.
  • E.E. Geduld's biggest Q3 2015 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $578K.
  • E.E. Geduld fully exited bluebird bio in Q3 2015, selling an estimated $1.75M.
  • E.E. Geduld's ten largest holdings make up 55% of its $107M portfolio in Q3 2015.
  • E.E. Geduld opened 45 new positions and closed 132 in Q3 2015.
  • E.E. Geduld's portfolio value fell 34% quarter-over-quarter to $107M.

Based on E.E. Geduld's 13F filing for Q3 2015, filed 6 Nov 2015.